지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.8
- 수록면
- 349 - 357 (9page)
이용수
초록· 키워드
오류제보하기
Backgrounds/Aims: Surgical resection is the only curative treatment for biliary tract cancers; however, most patients undergo palliative chemotherapy because they are contraindicated for surgery. Conversion surgery, a treatment strategy for downsizing chemotherapy and subsequent surgical resection, is feasible for initially unresectable biliary tract cancers following the introduction of effective chemotherapeutic agents.
Methods: Patients initially diagnosed with unresectable biliary tract cancers, and treated with conversion surgery after palliative chemotherapy between 2013 and 2019, were reviewed retrospectively.
Results: Twelve patients underwent conversion surgery after palliative chemotherapy for initially unresectable biliary tract cancers. The final pathological diagnosis included six perihilar cholangiocarcinomas, four distal common bile duct cancers, and two gallbladder cancers. Different chemotherapy regimens were used, but all the patients were treated with gemcitabine at some point during their treatment. The median overall survival was 28 months, which was longer than that of patients treated with isolated palliative chemotherapy in previous studies.
Conclusions: Conversion surgery represents a therapeutic alternative for specific cases of unresectable biliary tract cancers. Palliative chemotherapy for initially unresectable biliary tract cancers is recommended for downsizing the tumor and expanding the indications for surgery. Further studies and clinical trials are required to develop new and effective chemotherapeutic regimens.
Methods: Patients initially diagnosed with unresectable biliary tract cancers, and treated with conversion surgery after palliative chemotherapy between 2013 and 2019, were reviewed retrospectively.
Results: Twelve patients underwent conversion surgery after palliative chemotherapy for initially unresectable biliary tract cancers. The final pathological diagnosis included six perihilar cholangiocarcinomas, four distal common bile duct cancers, and two gallbladder cancers. Different chemotherapy regimens were used, but all the patients were treated with gemcitabine at some point during their treatment. The median overall survival was 28 months, which was longer than that of patients treated with isolated palliative chemotherapy in previous studies.
Conclusions: Conversion surgery represents a therapeutic alternative for specific cases of unresectable biliary tract cancers. Palliative chemotherapy for initially unresectable biliary tract cancers is recommended for downsizing the tumor and expanding the indications for surgery. Further studies and clinical trials are required to develop new and effective chemotherapeutic regimens.
목차
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Clinical outcomes and prognostic analysis of conversion surgery for initially unresectable biliary tract cancer: Japan-Korea collaboration study
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Conversion surgery following neoadjuvant therapy for advanced biliary tract cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
A study of biliary microbiota in patients with biliary tract disease
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Short-course radiotherapy and chemotherapy for conversion surgery in patients with unresectable metastatic rectal cancer: a preliminary case series study
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2021 .12
-
Conversion surgery after palliative chemotherapy for metastatic gallbladder cancer
대한외과학회 학술대회 초록집
2019 .10
-
Relationship between biliary tract cancer and coffee consumption in urban population
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Preoperative C-reactive protein as a prognostic factor for recurrence after surgical resection of biliary tract cancer
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2015 .12
-
Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: A population-based study
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Liquid biopsy from bile-circulating tumor DNA in patients with biliary tract cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database
Gut and Liver
2019 .01
-
Genetic aberration from normal tissues adjacent to biliary tract cancers
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
The Role of Palliative Resection for Asymptomatic Primary Tumor in Patients with Unresectable Stage IV Colorectal Cancer
대한임상종양학회 학술대회지
2016 .02
-
진행성 담도암과 췌장암에서 혈전색전증의 임상적 예후인자로서의 의의
대한내과학회지
2018 .01
-
Impact of conversion surgery in gastric cancer
대한임상종양학회 학술대회지
2021 .06
-
MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers
Gut and Liver
2016 .01
-
Changing Trends in Biliary Stenting for Unresectable Malignant Perihilar Obstructions
Clinical Endoscopy
2020 .01
-
[Hepato-Biliary and Pancreas] Impact of Volumetric Parameters on 18F-FDG PET-CT in Pancreatic and Biliary Tract Cancer
대한외과학회 학술대회 초록집
2021 .11
-
HDAC-targeting epigenetic drug screening for biliary tract cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
췌장 및 담도암 환자의 항암 시작, 반응 평가 및 항암 중단 시점
대한췌담도학회지
2020 .01
-
Preoperative biliary drainage for pancreatic cancer
International Journal of Gastrointestinal Intervention
2018 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2021-514-001920697